Literature DB >> 23722164

Nrf2 activation: a potential strategy for the prevention of acute mountain sickness.

Christina Lisk1, Joe McCord, Swapan Bose, Tim Sullivan, Zoe Loomis, Eva Nozik-Grayck, Thies Schroeder, Karyn Hamilton, David C Irwin.   

Abstract

Reactive oxygen species (ROS) formed during acute high altitude exposure contribute to cerebral vascular leak and development of acute mountain sickness (AMS). Nuclear factor (erythroid-derived 2)-related factor 2 (Nrf2) is a transcription factor that regulates expression of greater than 90% of antioxidant genes, but prophylactic treatment with Nrf2 activators has not yet been tested as an AMS therapy. We hypothesized that prophylactic activation of the antioxidant genome with Nrf2 activators would attenuate high-altitude-induced ROS formation and cerebral vascular leak and that some drugs currently used to treat AMS symptoms have an additional trait of Nrf2 activation. Drugs commonly used to treat AMS were screened with a luciferase reporter cell system for their effectiveness to activate Nrf2, as well as being tested for their ability to decrease high altitude cerebral vascular leak in vivo. Compounds that showed favorable results for Nrf2 activation from our screen and attenuated high altitude cerebral vascular leak in vivo were further tested in brain microvascular endothelial cells (BMECs) to determine if they attenuated hypoxia-induced ROS production and monolayer permeability. Of nine drugs tested, with the exception of dexamethasone, only drugs that showed the ability to activate Nrf2 (Protandim, methazolamide, nifedipine, amlodipine, ambrisentan, and sitaxentan) decreased high-altitude-induced cerebral vascular leak in vivo. In vitro, Nrf2 activation in BMECs before 24h hypoxia exposure attenuated hypoxic-induced hydrogen peroxide production and permeability. Prophylactic Nrf2 activation is effective at reducing brain vascular leak from acute high altitude exposures. Compared to acetazolamide, methazolamide may offer better protection against AMS. Nifedipine, in addition to its known vasodilatory activities in the lung and protection against high altitude pulmonary edema, may provide protection against brain vascular leak as well.
Copyright © 2013 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Calcium channel blockers; Carbon anhydrase inhibitors; Cerebral; Endothelin receptor antagonist; Free radicals; High altitude sickness; Nrf2; Vascular leak

Mesh:

Substances:

Year:  2013        PMID: 23722164      PMCID: PMC4130652          DOI: 10.1016/j.freeradbiomed.2013.05.024

Source DB:  PubMed          Journal:  Free Radic Biol Med        ISSN: 0891-5849            Impact factor:   7.376


  36 in total

Review 1.  Acute mountain sickness: pathophysiology, prevention, and treatment.

Authors:  Chris Imray; Alex Wright; Andrew Subudhi; Robert Roach
Journal:  Prog Cardiovasc Dis       Date:  2010 May-Jun       Impact factor: 8.194

2.  Single-dose kinetics of nifedipine in rat plasma and brain.

Authors:  P K Janicki; D Siembab; E A Paulo; P Krzaścik
Journal:  Pharmacology       Date:  1988       Impact factor: 2.547

Review 3.  Pharmacologic prophylaxis for acute mountain sickness: a systematic shortcut review.

Authors:  Rawle A Seupaul; Julie L Welch; Sarah T Malka; Thomas W Emmett
Journal:  Ann Emerg Med       Date:  2011-12-07       Impact factor: 5.721

Review 4.  New insights in the pathogenesis of high-altitude pulmonary edema.

Authors:  Urs Scherrer; Emrush Rexhaj; Pierre-Yves Jayet; Yves Allemann; Claudio Sartori
Journal:  Prog Cardiovasc Dis       Date:  2010 May-Jun       Impact factor: 8.194

5.  Pathophysiological significance of peroxidative stress, neuronal damage, and membrane permeability in acute mountain sickness.

Authors:  Damian M Bailey; Gian-Reto Kleger; Manfred Holzgraefe; Peter E Ballmer; Peter Bärtsch
Journal:  J Appl Physiol (1985)       Date:  2003-10-31

6.  Synergistic induction of heme oxygenase-1 by the components of the antioxidant supplement Protandim.

Authors:  Kalpana Velmurugan; Jawed Alam; Joe M McCord; Subbiah Pugazhenthi
Journal:  Free Radic Biol Med       Date:  2008-11-17       Impact factor: 7.376

7.  The Dietary Supplement Protandim Decreases Plasma Osteopontin and Improves Markers of Oxidative Stress in Muscular Dystrophy Mdx Mice.

Authors:  Muhammad Muddasir Qureshi; Warren C McClure; Nicole L Arevalo; Rick E Rabon; Benjamin Mohr; Swapan K Bose; Joe M McCord; Brian S Tseng
Journal:  J Diet Suppl       Date:  2010-06-01

8.  Mixed S-nitrosylated polymerized bovine hemoglobin species moderate hemodynamic effects in acutely hypoxic rats.

Authors:  David Irwin; Paul W Buehler; Abdu I Alayash; Yiping Jia; Joe Bonventura; Ben Foreman; Molly White; Robert Jacobs; Brian Piteo; Martha C TissotvanPatot; Karyn L Hamilton; Robert W Gotshall
Journal:  Am J Respir Cell Mol Biol       Date:  2009-04-24       Impact factor: 6.914

9.  Dose translation from animal to human studies revisited.

Authors:  Shannon Reagan-Shaw; Minakshi Nihal; Nihal Ahmad
Journal:  FASEB J       Date:  2007-10-17       Impact factor: 5.191

Review 10.  Emerging concepts in acute mountain sickness and high-altitude cerebral edema: from the molecular to the morphological.

Authors:  Damian Miles Bailey; Peter Bärtsch; Michael Knauth; Ralf W Baumgartner
Journal:  Cell Mol Life Sci       Date:  2009-09-10       Impact factor: 9.261

View more
  22 in total

1.  Nrf2 regulates PU.1 expression and activity in the alveolar macrophage.

Authors:  Bashar S Staitieh; Xian Fan; Wendy Neveu; David M Guidot
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2015-04-03       Impact factor: 5.464

Review 2.  New insights into carbonic anhydrase inhibition, vasodilation, and treatment of hypertensive-related diseases.

Authors:  Erik R Swenson
Journal:  Curr Hypertens Rep       Date:  2014-09       Impact factor: 5.369

3.  Acclimatization of the systemic microcirculation to alveolar hypoxia is mediated by an iNOS-dependent increase in nitric oxide availability.

Authors:  Alfred J Casillan; Jie Chao; John G Wood; Norberto C Gonzalez
Journal:  J Appl Physiol (1985)       Date:  2017-03-16

4.  Dental Pulp-Derived Stem Cells Preserve Astrocyte Health During Induced Gliosis by Modulating Mitochondrial Activity and Functions.

Authors:  Derek Barthels; Prateeksha Prateeksha; Saeideh Nozohouri; Heidi Villalba; Yong Zhang; Sejal Sharma; Sarah Anderson; Md Sariful Islam Howlader; Adarsh Nambiar; Thomas J Abbruscato; Hiranmoy Das
Journal:  Cell Mol Neurobiol       Date:  2022-10-06       Impact factor: 4.231

5.  Exploratory proteomic analysis of hypobaric hypoxia and acute mountain sickness in humans.

Authors:  Colleen G Julian; Andrew W Subudhi; Ryan C Hill; Megan J Wilson; Andrew C Dimmen; Kirk C Hansen; Robert C Roach
Journal:  J Appl Physiol (1985)       Date:  2013-11-21

6.  Topical application of RTA 408 lotion activates Nrf2 in human skin and is well-tolerated by healthy human volunteers.

Authors:  Scott A Reisman; Angela R Goldsberry; Chun-Yue I Lee; Megan L O'Grady; Joel W Proksch; Keith W Ward; Colin J Meyer
Journal:  BMC Dermatol       Date:  2015-07-14

Review 7.  Role of Carbonic Anhydrase in Cerebral Ischemia and Carbonic Anhydrase Inhibitors as Putative Protective Agents.

Authors:  Irene Bulli; Ilaria Dettori; Elisabetta Coppi; Federica Cherchi; Martina Venturini; Lorenzo Di Cesare Mannelli; Carla Ghelardini; Alessio Nocentini; Claudiu T Supuran; Anna Maria Pugliese; Felicita Pedata
Journal:  Int J Mol Sci       Date:  2021-05-10       Impact factor: 5.923

Review 8.  The clinical potential of influencing Nrf2 signaling in degenerative and immunological disorders.

Authors:  Bifeng Gao; An Doan; Brooks M Hybertson
Journal:  Clin Pharmacol       Date:  2014-02-03

9.  Glutathione protects brain endothelial cells from hydrogen peroxide-induced oxidative stress by increasing nrf2 expression.

Authors:  Juhyun Song; So Mang Kang; Won Taek Lee; Kyung Ah Park; Kyoung Min Lee; Jong Eun Lee
Journal:  Exp Neurobiol       Date:  2014-03-27       Impact factor: 3.261

10.  Ameliorative Effect of a Selective Endothelin ETA Receptor Antagonist in Rat Model of L-Methionine-induced Vascular Dementia.

Authors:  Gautamjeet S Mangat; Amteshwar S Jaggi; Nirmal Singh
Journal:  Korean J Physiol Pharmacol       Date:  2014-06-12       Impact factor: 2.016

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.